ONCOZ (ONCOZ) News
Track canonical SquawkNews coverage tagged to ONCOZ, ONCOZ. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
ONCOZ investor withholds remaining fourth-tranche payment
An investor withheld the remaining payment for the fourth tranche, creating a short-term liquidity shortfall for ONCOZ.
EQUITY | Aug 27, 2026, 06:15 PM UTC
L
ONCOZ cites European Phase III approval, milestone payments
ONCOZ says European Phase III approval and milestone payments support funding efforts amid rising R&D costs.
EQUITY | Aug 27, 2026, 06:07 AM UTC
L
OncoZenge AB files interim report for Jan 1–Jun 30, 2026
OncoZenge AB released an interim report covering January 1 through June 30, 2026.
EQUITY | Aug 27, 2026, 06:00 AM UTC
L
OncoZenge announces SEK33.3m rights issue
OncoZenge said it has announced a SEK33.3m rights issue, according to TradingView News.
EQUITY | Aug 26, 2026, 09:20 AM UTC